ROZZINI, Luca
 Distribuzione geografica
Continente #
NA - Nord America 7.547
AS - Asia 3.604
EU - Europa 3.479
SA - Sud America 704
AF - Africa 121
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 6
Totale 15.468
Nazione #
US - Stati Uniti d'America 7.429
CN - Cina 1.364
SG - Singapore 1.137
UA - Ucraina 847
BR - Brasile 577
PL - Polonia 520
DE - Germania 504
IT - Italia 462
HK - Hong Kong 408
FI - Finlandia 313
VN - Vietnam 241
FR - Francia 216
GB - Regno Unito 202
RU - Federazione Russa 137
IE - Irlanda 122
TR - Turchia 121
IN - India 101
NG - Nigeria 60
CA - Canada 51
AR - Argentina 49
BD - Bangladesh 46
MX - Messico 39
IQ - Iraq 27
SE - Svezia 27
ZA - Sudafrica 24
JP - Giappone 23
NL - Olanda 22
ID - Indonesia 21
PK - Pakistan 20
AT - Austria 19
BE - Belgio 19
EC - Ecuador 17
IR - Iran 17
VE - Venezuela 15
MA - Marocco 14
SA - Arabia Saudita 12
CO - Colombia 11
PY - Paraguay 11
UZ - Uzbekistan 11
CL - Cile 10
ES - Italia 10
CH - Svizzera 8
CZ - Repubblica Ceca 7
EU - Europa 7
KR - Corea 7
LT - Lituania 7
AE - Emirati Arabi Uniti 6
AU - Australia 6
DO - Repubblica Dominicana 6
HU - Ungheria 6
JO - Giordania 6
PE - Perù 6
LV - Lettonia 5
TW - Taiwan 5
AL - Albania 4
EG - Egitto 4
JM - Giamaica 4
KE - Kenya 4
UY - Uruguay 4
AZ - Azerbaigian 3
BG - Bulgaria 3
BO - Bolivia 3
BY - Bielorussia 3
CR - Costa Rica 3
DK - Danimarca 3
DZ - Algeria 3
HN - Honduras 3
KW - Kuwait 3
MU - Mauritius 3
MY - Malesia 3
NP - Nepal 3
PS - Palestinian Territory 3
BH - Bahrain 2
CI - Costa d'Avorio 2
GE - Georgia 2
GT - Guatemala 2
IL - Israele 2
KG - Kirghizistan 2
KZ - Kazakistan 2
NI - Nicaragua 2
PA - Panama 2
RS - Serbia 2
SI - Slovenia 2
SN - Senegal 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
BB - Barbados 1
BJ - Benin 1
EE - Estonia 1
ET - Etiopia 1
FK - Isole Falkland (Malvinas) 1
GA - Gabon 1
GR - Grecia 1
IS - Islanda 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LY - Libia 1
MN - Mongolia 1
MT - Malta 1
NO - Norvegia 1
Totale 15.459
Città #
Fairfield 974
Woodbridge 791
Ashburn 629
Singapore 594
Jacksonville 556
Warsaw 519
Houston 505
Hong Kong 407
Wilmington 375
Cambridge 363
Seattle 361
Ann Arbor 307
Beijing 259
Princeton 221
Nanjing 219
The Dalles 214
San Jose 211
Chandler 208
Helsinki 188
New York 164
Dublin 122
Brescia 121
Los Angeles 114
Istanbul 104
Lauterbourg 102
Munich 95
Ho Chi Minh City 81
Milan 76
Nanchang 72
Dallas 68
Abuja 58
Hebei 55
Buffalo 54
Des Moines 49
Moscow 48
São Paulo 47
Shanghai 46
Changsha 45
San Diego 45
Dearborn 44
Hanoi 43
Jinan 41
Tianjin 41
Shenyang 38
Redondo Beach 37
San Francisco 37
Nuremberg 30
Council Bluffs 27
Jiaxing 27
Hangzhou 26
Turku 25
Orem 24
Kunming 23
Dong Ket 22
Chicago 20
Santa Clara 20
Toronto 20
Verona 20
Brussels 19
London 19
Montreal 18
Zhengzhou 18
Rio de Janeiro 16
San Mateo 16
Boardman 15
Denver 15
Guangzhou 15
Ningbo 15
Augusta 14
Brooklyn 14
Lanzhou 14
Mumbai 14
Poplar 14
Ardabil 13
Frankfurt am Main 13
Johannesburg 13
Rome 13
Stockholm 13
Belo Horizonte 12
Manchester 12
Newton Abbot 12
Phoenix 12
Tokyo 12
Amsterdam 11
Charlotte 11
Chennai 11
Jakarta 11
Mexico City 11
Tashkent 11
Boston 10
Da Nang 10
Haikou 10
Leawood 10
Baghdad 9
Bologna 9
Osasco 9
Salò 9
Thái Bình 9
Washington 9
Erbil 8
Totale 10.561
Nome #
Neuropsychiatric symptoms and syndromes in a large cohort of newly diagnosed, untreated patients with Alzheimer disease. 334
Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy 304
Gene expression profile in fibroblasts of Huntington's disease patients and controls 278
Behavioral disorders in Alzheimer disease: a transcultural perspective 274
"Delirium Day": A nationwide point prevalence study of delirium in older hospitalized patients using an easy standardized diagnostic tool 266
COVID-19 impact on consecutive neurological patients admitted to the emergency department 252
Efficacy of SSRIs on cognition of Alzheimer's disease patients treated with cholinesterase inhibitors. 244
Discrimination of atypical parkinsonisms with transcranial magnetic stimulation 235
Diagnosis of Mild Cognitive Impairment Due to Alzheimer's Disease with Transcranial Magnetic Stimulation 216
Gene expression profile in fibroblasts of Huntington's disease patients and controls. 213
Social networks and health status in the elderly: the ‘ANZIANI IN-RETE’ population-based study 207
A case report: doctor, my daughter has Alzheimer's disease. 200
Do Beliefs about the Pathogenetic Role of Amyloid Affect the Interpretation of Amyloid PET in the Clinic. 199
The Italian version of the pain assessment in advanced dementia (PAINAD) scale 191
Transcranial magnetic stimulation distinguishes Alzheimer disease from frontotemporal dementia 180
Platelet amyloid precursor protein abnormalities in mild cognitive impairment predict conversion to dementia of Alzheimer type: a 2-year follow-up study. 179
Serum Non-Ceruloplasmin Non-Albumin Copper Elevation in Mild Cognitive Impairment and Dementia due to Alzheimer’s Disease: A Case Control Study 175
Cognitive dysfunction and age-related macular degeneration. 173
Odor identification deficit predicts clinical conversion from mild cognitive impairment to dementia due to Alzheimer's disease. 171
The Italian dementia with Lewy bodies study group (DLB-SINdem): toward a standardization of clinical procedures and multicenter cohort studies design 170
Depressive disorders in dementia. 167
Acetylcholinesterase inhibitors and depressive symptoms in patients with mild to moderate Alzheimer's disease. 166
Amyloid precursor protein in platelets: a peripheral marker for the diagnosis of sporadic AD 166
Diagnosis disclosure and advance care planning in Alzheimer disease: opinions of a sample of Italian citizens. 164
Impaired financial abilities in mild cognitive impairment: a direct assessment approach. 163
Non-amnestic mild cognitive impairment and sleep complaints: a bidirectional relationship? 163
Gene expression profile in fibroblasts of Huntington's disease patients and controls 162
Antihypertensive medications influence the rate of conversion from mild cognitive impairment to Alzheimer disease. 162
Alzheimer disease and frontotemporal dementia. 157
The Italian Version of the Five-Word Test: A Simple Diagnostic Test for Dementia due to Alzheimer's Disease in Routine Clinical Practice 155
Anxiety symptoms in mild cognitive impairment. 154
Prestroke dementia: characteristics and clinical features in consecutive series of patients. 153
Differential Impact of Apathy and Depression in the Development of Dementia in Mild Cognitive Impairment Patients 151
Free copper in serum: An analytical challenge and its possible applications 149
Behavioral syndromes in Alzheimer's disease: description and correlates. 148
Pre-stroke and post-stroke dementia: Preliminary data from an Italian study 148
Procedural memory stimulation in Alzheimer's disease: impact of a training programme. 147
Predictors of progression from mild cognitive impairment to Alzheimer disease. 147
Does age at observation time affect the clinical presentation of mild cognitive impairment? 145
Does reversible MCI exist? 145
Do vascular risk factors play a role in the progression of mild cognitive impairment? 144
Angiotensin converting enzyme (ACE) inhibitors modulate the rate of progression of amnestic mild cognitive impairment 143
Neuropsychiatric symptoms in amnestic and nonamnestic mild cognitive impairment. 142
Severe worsening of parkinsonism in Lewy body dementia due to donepezil. 142
Early stages of probable Alzheimer disease are associated with changes in platelet amyloid precursor protein forms. 138
Assessment of the Incremental Diagnostic Value of Florbetapir F 18 Imaging in Patients With Cognitive Impairment: The Incremental Diagnostic Value of Amyloid PET With [18F]-Florbetapir (INDIA-FBP) Study. 136
Mild parkinsonian signs and psycho-behavioral symptoms in subjects with mild cognitive impairment. 134
Cognitive and psychopathologic response to rivastigmine in dementia with Lewy bodies compared to Alzheimer's disease: a case control study 134
Differential Impact of Apathy and Depression in the Development of Dementia in Mild Cognitive Impairment Patients 133
Potential source of cerebral embolism in migraine with aura: a transcranial Doppler study. 133
Effects of cholinesterase inhibitors appear greater in patients on established antihypertensive therapy. 130
Transcranial Doppler and risk of recurrence in patients with stroke and patent foramen ovale. 129
Validity of direct assessment of functional status as a tool for measuring Alzheimer's disease severity. 128
Serum albumin level interferes with the effect of donepezil in Alzheimer's disease 127
The importance of Alzheimer disease assessment scale-cognitive part in predicting progress for amnestic mild cognitive impairment to Alzheimer disease. 125
Object and action naming in Alzheimer's disease and frontotemporal dementia 125
The migraine-PFO connection is independent of sex. 125
Microvascular damage and platelet abnormalities in early Alzheimer's disease. 124
Alteration of APP processing in platelets and CSF of AD patients European 124
Transient global amnesia and venous flow patterns. 123
Serum albumin level interferes with the effect of donepezil in Alzheimer's disease. 122
Surface dyslexia in an Italian patient with semantic dementia 122
Amyloid precursor protein in platelets of patients with Alzheimer disease: effect of acetylcholinesterase inhibitor treatment. 121
Prevalence and demographic features of early-onset neurodegenerative dementia in Brescia County, Italy. 119
The impact of cognitive deficit on self-reported car crashes in ultra-octogenarian population: data of an Italian population-based study. 119
Spatial navigation in elderly healthy subjects, amnestic and non amnestic MCI patients 119
Cognitive and psychopathologic response to rivastigmine in dementia with Lewy bodies compared to Alzheimer's disease: a case control study. 118
Assessment of platelet Amyloid Precursor Protein forms ratio in patients with mild cognitive impairment: A tool for the identification of preclinical Alzheimer Disease 117
Acetylcholinestfrase inhibitors are effective in "real world" patients with mild to moderate Alzheimer disease: Evidence from a large population treated with rivastigmine or donepezil 116
Changes in characteristics of Alzheimer patients at first visit to centers for dementia: a 10-year follow-up study. 116
App isoforms ratio in platelets: A peripheral marker for the diagnosis and treatment of Alzheimer's disease? 115
Transient global amnesia and disturbance of venous flow patterns 115
Incidence of and risk factors for hallucinations and delusions in patients with probable AD. 113
Transient global amnesia: a clinical and sonographic study 113
Predictors of institutionalization in demented patients discharged from a rehabilitation unit 112
How legislation on decisional capacity can negatively affect the feasibility of clinical trials in patients with dementia. 111
Volume reduction in cerebral blood flow in patients with Alzheimer’s disease. A sonographic study 110
Mild parkinsonian signs and psycho-behavioral symptoms in subjects with mild cognitive impairment. 109
Efficacy of SSRI on cognition of Alzheimer's disease patients treated with cholinesterase inhibitors 107
Clinical correlates of executive dysfunctions in mild cognitive impairment 107
Knowledge and attitudes about Alzheimer's disease in the lay public: influence of caregiving experience and other socio-demographic factors in an Italian sample. 106
Efficacy of cognitive rehabilitation in patients with mild cognitive impairment treated with cholinesterase inhibitors. 105
Parkinsonian signs in subjects with mild cognitive impairment 105
Aspetti etici delle demenze 105
Conversion of amnestic Mild Cognitive Impairment to dementia of Alzheimer type is independent to memory deterioration. 102
Apolipoprotein E allele and platelets amyloid precursor protein in Alzheimer's disease: Biological effect of acetylcholinesterase inhibitors treatment 99
Rilevazione di segnali disgrafici e grafo-patologici in un gruppo di persone affette da demenza 99
Depression is unrelated to conversion to dementia in patients with mild cognitive impairment. 98
Results of a multi-level therapeutic approach for Alzheimer's disease subjects in the "real world" (CRONOS project): a 36-week follow-up study 96
Short-term memory binding in mild cognitive impairment: a preclinical marker of Alzheimer's disease? 89
Predictors of recurence in paradoxical cerebral embolism 89
Platelet Amyloid Precursor Protein ratio as a biochemical marker for Alzheimer disease: Sensitivity and specificity 88
Retrograde jugular venous flow is a predisposing factor in transient global amnesia. 87
Vascular risk factors for VaD and AD in a population-based prospective cohort. The PAQUID study 87
Peripheral oedema related to quetiapine therapy : a case report. 85
Prevalence and features of delirium in older patients admitted to rehabilitation facilities: a multicenter study 83
L’Istituto di Riabilitazione Geriatrica (IDRG): un modello clinico-assistenziale per le demenze? 83
Il progetto Cronos e le Unità di Valutazione Alzheime 83
La depressione dell'anziano: un rilevante fattore di modulazione prognostica 82
Platelet Amyloid Precursor Protein ratio as a biochemical marker for Alzheimer disease: Sensitivity and specificity 81
Totale 14.365
Categoria #
all - tutte 66.559
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.559


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021485 0 0 0 0 0 0 0 0 0 172 242 71
2021/2022859 39 198 9 39 7 36 53 56 50 101 55 216
2022/2023691 129 21 12 35 65 207 6 61 91 4 25 35
2023/2024740 48 25 73 43 21 123 29 26 213 13 9 117
2024/20251.963 10 22 22 268 239 169 222 53 213 117 402 226
2025/20263.846 355 551 315 638 354 308 634 198 236 257 0 0
Totale 15.642